Systematic Review
Accepted on 18 Feb 2026
Febuxostat effectively reduces uric acid but has a limited renoprotective effect on renal transplant recipients with hyperuricemia: a meta-analysis
in Renal Pharmacology
Systematic Review
Accepted on 18 Feb 2026
in Renal Pharmacology
Original Research
Accepted on 18 Feb 2026
in Infectious Agents and Disease
Original Research
Accepted on 18 Feb 2026
in Brain Health and Clinical Neuroscience
Original Research
Accepted on 18 Feb 2026
in Non-Neuronal Cells
Original Research
Accepted on 18 Feb 2026
in Public Health Policy
Original Research
Accepted on 18 Feb 2026
in Cancer Immunity and Immunotherapy
Editorial
Accepted on 18 Feb 2026
in Multi- and Hyper-Spectral Imaging
Case Report
Accepted on 18 Feb 2026
in Radiation Oncology
Review
Accepted on 18 Feb 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 18 Feb 2026
in Oral Microbes and Host
Original Research
Accepted on 18 Feb 2026
in Public Health Education and Promotion
Original Research
Accepted on 18 Feb 2026
in Pharmacology of Anti-Cancer Drugs
Review
Accepted on 18 Feb 2026
in Virology
Case Report
Accepted on 18 Feb 2026
in Genitourinary Oncology
Original Research
Accepted on 18 Feb 2026
in Cognitive Neuroscience
Original Research
Accepted on 18 Feb 2026
in Endourology